Phototherapy Equipment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, Fiber Optic Phototherapy Equipment), By Application (Skin Diseases Treatment, Psoriasis, Vitiligo, Eczema, others), By End-use (Hospitals & Clinics, Homecare, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 491.01 Million
CAGR (2026-2031)	5.38%
Fastest Growing Segment	LED Phototherapy Equipment
Largest Market	North America
Market Size (2031)	USD 672.42 Million

Market Overview

The Global Phototherapy Equipment Market will grow from USD 491.01 Million in 2025 to USD 672.42 Million by 2031 at a 5.38% CAGR. Phototherapy equipment comprises medical devices that utilize specific wavelengths of light, including ultraviolet and fluorescent sources, to treat dermatological conditions such as psoriasis, vitiligo, and neonatal jaundice. The primary driver supporting market growth is the rising incidence of chronic skin diseases combined with the essential requirement for effective non-invasive treatments for infants. Furthermore, the demand for cost-effective therapeutic alternatives to systemic medications continues to stimulate the adoption of these devices in both clinical and home care settings.

Despite these positive factors, the market faces a significant challenge regarding the potential long-term safety risks associated with ultraviolet radiation exposure, including erythema and skin malignancy, which may limit patient adherence. According to the American Academy of Dermatology, in 2025, the prevalence of psoriasis among adults in the United States was estimated at 3.0 percent. This substantial patient volume underscores the critical necessity for phototherapy solutions, although safety concerns remain a hurdle to broader market expansion.

Key Market Drivers

The rising global prevalence of chronic dermatological conditions is a primary catalyst for the Global Phototherapy Equipment Market. As autoimmune disorders such as atopic dermatitis and psoriasis escalate, reliance on phototherapy as a critical non-pharmacological intervention grows. According to the International League of Dermatological Societies, as highlighted in the Skin Allergy Journal in February 2025, atopic dermatitis affects an estimated 204 million people worldwide. This massive patient population creates sustained demand for phototherapy units in dermatology clinics to manage flare-ups. Moreover, the market opportunity is amplified by the high volume of patients with uncontrolled disease; according to the National Psoriasis Foundation, January 2025, survey data indicated that 79.3 percent of psoriasis patients reported they were not in remission, underscoring the urgent necessity for effective therapeutic modalities like light therapy to improve clinical outcomes.

Simultaneously, the rising awareness of phototherapy efficacy among healthcare professionals is stimulating higher utilization rates of advanced equipment. Dermatologists are increasingly prioritizing targeted light treatments due to their safety profile and effectiveness compared to systemic medications, leading to greater device productivity. This trend is evident in the performance metrics of leading technology providers. According to Strata Skin Sciences, March 2025, in the 'Fourth Quarter and Full-Year 2024 Financial Results', the average net revenue per domestic XTRAC system increased to $5,906 in the fourth quarter of 2024, reflecting a 6 percent growth year-over-year. Such data indicates that as clinicians become more cognizant of the therapeutic benefits, the usage intensity of installed phototherapy infrastructure rises, thereby propelling market value and encouraging further adoption.

Download Free Sample Report

Key Market Challenges

The potential long-term safety risks associated with ultraviolet radiation exposure constitute a primary restraint for the phototherapy equipment market. Clinical concerns regarding adverse effects, specifically erythema and the elevated risk of skin malignancy, create hesitation among both healthcare providers and patients. This apprehension directly impacts the adoption rate of phototherapy devices as patients often seek to avoid treatments that may compound their health issues. Consequently, the preference for biological drugs or other systemic alternatives that do not involve radiation exposure creates a competitive barrier for device manufacturers.

Regulatory bodies and medical associations frequently emphasize the correlation between cumulative UV exposure and skin damage which further dampens market momentum. This risk factor is substantiated by recent health data regarding skin pathologies. According to the Skin Cancer Foundation, in 2024, an estimated 200,340 cases of melanoma were diagnosed in the United States. Such statistics reinforce the rigorous safety protocols required for phototherapy thereby increasing the administrative burden on clinics and limiting the widespread utilization of these devices for chronic skin management.

Key Market Trends

The proliferation of home-based treatment solutions is transitioning care from clinical settings to domestic environments. This trend is driven by the development of user-friendly, portable devices that allow patients to manage chronic conditions like psoriasis in privacy, reducing the burden of frequent hospital visits. The shift is strongly supported by recent clinical data demonstrating that remote treatment efficacy rivals in-office procedures. According to the American Academy of Dermatology, March 2024, in the 'Light Treatment Effectiveness (LITE) study', 32.8 percent of patients randomized to home phototherapy achieved clear or almost clear skin after 12 weeks, compared to 25.6 percent of those receiving office-based treatments. Such evidence of non-inferiority is catalyzing the wider adoption of home units as a primary therapeutic option.

Simultaneously, the market is expanding its scope beyond traditional medical pathology into aesthetic and acne-related applications. Manufacturers are increasingly commercializing equipment designed to treat cosmetic concerns, thereby accessing a broader demographic of patients seeking non-invasive skin rejuvenation and active acne management. This diversification is evident in the commercial scaling of specialized technologies that bridge the gap between medical dermatology and aesthetics. According to Strata Skin Sciences, May 2024, in the 'Strata Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices' report, the company confirmed that the installed base of its proprietary photo-pneumatic acne treatment system had surpassed 100 units in the United States. This growth trajectory highlights the increasing market appetite for versatile phototherapy solutions capable of delivering aesthetic improvements.

Segmental Insights

The LED Phototherapy Equipment segment is currently the fastest-growing category within the Global Phototherapy Equipment Market. This rapid expansion is primarily driven by the superior safety profile of LED technology, which generates minimal heat and eliminates the ultraviolet radiation risks associated with conventional fluorescent lamps. Consequently, these devices are increasingly utilized for treating neonatal jaundice and dermatological conditions like acne. Furthermore, the compact and energy-efficient nature of LEDs has facilitated a significant shift toward home-based care, as regulatory bodies such as the FDA increasingly clear portable devices for patient use, thereby broadening market accessibility.

Regional Insights

North America maintains a dominant position in the global phototherapy equipment market, driven primarily by the high prevalence of skin disorders such as psoriasis and eczema. The region benefits from a robust healthcare infrastructure and comprehensive reimbursement policies that significantly improve patient access to care. Furthermore, the proactive involvement of the U.S. Food and Drug Administration in approving medical devices encourages continuous product availability and safety compliance. The concentrated presence of key manufacturers within the United States and Canada also reinforces the region's strong market standing.

Recent Developments

• In November 2024, NeoLight announced that it had received a group purchasing agreement for its Skylife Neonatal Phototherapy System from Premier, Inc., a leading healthcare improvement company. This strategic contract allows the company to offer its advanced phototherapy technology to a vast network of hospitals and healthcare providers within the Premier alliance. The Skylife system is designed to treat neonatal jaundice effectively without the need for incubators, thereby facilitating better bonding between infants and their parents. This collaboration marks a significant commercial milestone, aiming to enhance the accessibility of high-quality jaundice treatment for newborns across the United States.
• In June 2024, Dermalux launched the Tri-Wave MD MK II, an innovative LED phototherapy system, during a premier industry event in London. This medical-grade device was engineered to deliver clinically proven wavelengths of light to treat a variety of dermatological conditions, including psoriasis, acne, and wound healing. The system features a versatile four-pod design that enables the simultaneous treatment of larger body areas and offers enhanced protocol customization for medical professionals. The introduction of this technology underscores the company's commitment to advancing non-invasive phototherapy solutions and providing practitioners with powerful tools to improve patient outcomes in clinical settings.
• In May 2024, Zerigo Health entered into a strategic partnership with Nextiva to offer its connected phototherapy solution as a health benefit to the latter’s employees. This collaboration provides individuals suffering from chronic skin conditions, such as psoriasis and eczema, with access to the company's FDA-cleared handheld narrowband UVB device and a supportive digital care platform. By integrating this home-based treatment into the employee benefits package, the initiative aims to improve health outcomes and reduce the logistical burden of frequent clinic visits. This partnership highlights a growing trend of employers adopting digital health solutions to support workforce well-being.
• In March 2024, significant findings from the Light Treatment Effectiveness (LITE) study, which utilized home phototherapy units manufactured by Daavlin, were presented at a major dermatology conference. The research demonstrated that home-based narrowband UVB phototherapy is non-inferior to office-based treatments for plaque and guttate psoriasis across all skin types. This breakthrough study provided critical clinical evidence supporting the efficacy and safety of home phototherapy devices, potentially influencing future reimbursement policies and treatment guidelines. The results underscored the value of the company's technology in increasing patient access to effective dermatological care and managing chronic skin diseases.

Key Market Players

• Signify Holding
• GE Healthcare
• Natus Medical Incorporated
• Hebert Waldmann GmbH & Co. KG
• Nice Neotech Medical Systems Pvt. Ltd.
• Atom Medical Corporation
• Phoenix Medical Systems Pvt. Ltd.
• National Biological Corp.
• Solarc Systems Inc.
• The Daavlin Company

By Product	By Application	By End-use	By Region
Conventional Phototherapy Equipment LED Phototherapy Equipment Fiber Optic Phototherapy Equipment	Skin Diseases Treatment Psoriasis Vitiligo Eczema others	Hospitals & Clinics Homecare Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Phototherapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Phototherapy Equipment Market, By Product:

• Conventional Phototherapy Equipment
• LED Phototherapy Equipment
• Fiber Optic Phototherapy Equipment

• Phototherapy Equipment Market, By Application:

• Skin Diseases Treatment
• Psoriasis
• Vitiligo
• Eczema
• others

• Phototherapy Equipment Market, By End-use:

• Hospitals & Clinics
• Homecare
• Others

• Phototherapy Equipment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE